Cresco Labs stock is down 5.2% on Thursday after the company announced the expiration of the necessary waiting period under the HSR Act ahead of its acquisition of Tryke Companies.
Cresco Labs Stock Down Due to Asset Light DealCresco Labs Inc (CSE:CL) (OTCQX:CRLBF) had announced the $282.5 million USD acquisition of the Nevada-based firm back in September, which also sent Cresco Labs stock tumbling as investors expressed their apprehension towards the deal. Tryke is a medical marijuana firm with considerable assets in Arizona, Utah, and its home state of Nevada, giving Cresco an enviable position ...
Read The Full Article On PotStockNews.com
Get the latest marijuana stock news, cannabis on stock news on PotStockNews
All content provided by Pot Stock News is subject to our Terms Of Use and Disclaimer.